NetRisk’s Ceske heads to GE Capital

Rob Ceske, head of business development at NetRisk and its subsidiary OpVantage, has left the company to take on a new role at GE Captial. Ceske’s departure from the Connecticut-based risk management company comes as it is being acquired by Fitch Risk Management, part of global rating agency Fitch.

Ceske told RiskNews that the timing of his move was “a coincidence” and had nothing to do with the Fitch acquisition.

Ceske largely led the development of the operational risk management business at NetRisk, which became known as OpVantage following the purchase of PricewaterhouseCoopers’ op risk business last year.

He also developed NetRisk’s insurance services and NetRisk/OpVantage’s banking consortium services. Prior to joining NetRisk – about four and a half years ago – Ceske was a managing associate in Coopers & Lybrand Consulting's financial risk management group, where he assisted financial, corporate and utility clients in improving market, credit and operations risk management practices.

He has previously worked as a vice-president and business manager in Merrill Lynch’s global commodity derivatives group, where he was responsible for risk management, financial, legal/regulatory, operations and systems. He also helped establish Merrill Lynch's credit derivatives capabilities. Before Merrill Lynch, Ceske worked at JP Morgan, where he managed the interest rate swap derivatives and structured derivatives support groups, and established a trader support group for commodity derivatives.

Ceske now heads the global risk management function at GE Capital’s treasury department.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here